[{"address1": "1920 Yonge Street", "address2": "Suite 200", "city": "Toronto", "state": "ON", "zip": "M4S 3E2", "country": "Canada", "phone": "416 847 6898", "fax": "416 847 6899", "website": "https://www.promisneurosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Mr. Eugene  Williams", "age": 64, "title": "Co-Founder & Chairman", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 439208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil K.  Warma M.B.A.", "age": 60, "title": "President, Interim CEO, Principal Executive Officer & Director", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil R. Cashman M.D.", "age": 71, "title": "Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director", "yearBorn": 1952, "fiscalYear": 2022, "totalPay": 333795, "exercisedValue": 0, "unexercisedValue": 274033}, {"maxAge": 1, "name": "Mr. Gavin T. Malenfant", "age": 59, "title": "Chief Operating Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 413489, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel E. Geffken M.B.A.", "age": 66, "title": "Chief Financial Officer", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": 90720, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Johanne  Kaplan Ph.D.", "age": 63, "title": "Chief Development Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 265212, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ernest D. Bush Ph.D.", "title": "Head of Pharmacology/Toxicology & Senior Consultant", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Wishart Ph.D.", "title": "Chief Physics Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dennis  Chen Ph.D.", "title": "Head of Manufacturing & Senior Consultant", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Larry Douglas Altstiel M.D., Ph.D.", "age": 73, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.01, "open": 2.07, "dayLow": 1.97, "dayHigh": 2.05, "regularMarketPreviousClose": 2.01, "regularMarketOpen": 2.07, "regularMarketDayLow": 1.97, "regularMarketDayHigh": 2.05, "beta": 0.66, "forwardPE": -1.9504951, "volume": 36261, "regularMarketVolume": 36261, "averageVolume": 45463, "averageVolume10days": 162240, "averageDailyVolume10Day": 162240, "bid": 1.96, "ask": 2.0, "bidSize": 1100, "askSize": 1100, "marketCap": 37204040, "fiftyTwoWeekLow": 0.95, "fiftyTwoWeekHigh": 8.95, "fiftyDayAverage": 1.432, "twoHundredDayAverage": 3.014, "currency": "USD", "enterpriseValue": 22361534, "floatShares": 11986660, "sharesOutstanding": 18885300, "sharesShort": 27155, "sharesShortPriorMonth": 16213, "sharesShortPreviousMonthDate": 1701302400, "dateShortInterest": 1703808000, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.23234, "heldPercentInstitutions": 0.14901, "shortRatio": 1.02, "shortPercentOfFloat": 0.0015, "impliedSharesOutstanding": 18885300, "bookValue": 0.365, "priceToBook": 5.39726, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -16897558, "trailingEps": -1.89, "forwardEps": -1.01, "lastSplitFactor": "1:60", "lastSplitDate": 1656374400, "enterpriseToEbitda": -1.054, "52WeekChange": -0.6292335, "SandP52WeekChange": 0.21123838, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PMN", "underlyingSymbol": "PMN", "shortName": "ProMIS Neurosciences Inc.", "longName": "ProMIS Neurosciences, Inc.", "firstTradeDateEpochUtc": 1168439400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "bf1a9156-d313-32e3-8126-86b4f443b286", "messageBoardId": "finmb_11795000", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.97, "targetHighPrice": 8.0, "targetLowPrice": 8.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 16919794, "totalCashPerShare": 0.896, "ebitda": -21206008, "quickRatio": 1.734, "currentRatio": 1.813, "returnOnAssets": -1.13999, "returnOnEquity": -4.51526, "freeCashflow": -5768503, "operatingCashflow": -11639066, "financialCurrency": "USD", "trailingPegRatio": null}]